New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
06:41 EDTIPXLImpax price target raised to $35 from $27 at Piper Jaffray
Piper Jaffray raised its price target for Impax shares to $35 saying it sees more upside potential than downside risk even with the absence of a resolution of the FDA warning letter related to the Hayward manufacturing facility. Piper reiterates an Overweight rating on the stock.
News For IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
10:01 EDTIPXLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:35 EDTIPXLImpax upgraded to Buy from Hold at WallachBeth
Subscribe for More Information
06:58 EDTIPXLImpax upgraded to Buy from Hold at Needham
Subscribe for More Information
October 9, 2014
07:21 EDTIPXLImpax to host conference call
Subscribe for More Information
06:13 EDTIPXLImpax to acquire Tower Holdings, Lineage Therapeutics for $700M cash
Subscribe for More Information
06:11 EDTIPXLImpax to acquire Tower Holdings, Lineage Therapeutics for $700M cash
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use